Inside the eye of a diabetic mouse, something remarkable was happening. A tiny cluster of laboratory-grown cells was learning to do what the mouse's own pancreas could no longer do: sense sugar in the blood and release insulin in the right amount. Month after month, the mouse's blood sugar stayed steady.
Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have refined a method for turning human stem cells into pancreatic islet cells that produce insulin. They tested this new approach in mice with diabetes, transplanting the cells into the eye, where they could be observed easily. The results were encouraging. The transplanted cells continued to mature inside the body, and the diabetic mice gradually regained control of their blood sugar for several months.
The study shows an important step in the search for a stem cell cure for type 1 diabetes, a disease where the immune system destroys insulin-producing cells. The new recipe produces cells that are more uniform and mature than earlier attempts. These cells respond to glucose the way a healthy pancreas does.
While a mouse is not a human, the findings offer hope for future treatments. The researchers believe this approach could eventually be tailored to individual patients using their own cells, which would lower the chance that the immune system rejects the transplant. For the millions of people living with type 1 diabetes worldwide, this represents real progress toward a potential cure.